13
Jan
2020
Phase II clinical trial of respiratory drug for treatment of Parkinson’s disease reveals promising results
NOTE: This release was originally published by The Cure Parkinson’s Trust. Results published today in the Journal of the American Medical Association... Read More
11
Oct
2018
ICYMI: Three big takeaways from Grand Challenges in Parkinson’s Disease
Did you miss Grand Challenges in Parkinson’s Disease and Rallying to the Challenge? Don’t worry. We have you covered. Just over a... Read More
14
Jun
2018
From discovery to medicine
Part three: What we’re doing to move lab discoveries into the clinic
In the past few weeks, VAI Voice has discussed what it takes to translate a promising laboratory discovery into a life-changing, approved... Read More
8
Sep
2016
Diabetes drug focus of new clinical trial for Parkinson’s disease
HIGHLIGHTS A clinical trial is now underway at Cedars-Sinai in Los Angeles to test the efficacy and safety of a type II... Read More
12
Jul
2016
Michael J. Fox Foundation, Van Andel Research Institute and The Cure Parkinson’s Trust collaborate to assess the clinical use and development of nilotinib in Parkinson’s disease
Note: To read the commentary published in the Journal of Parkinson’s Disease click here. Investigators will focus on safety for long-term use in non-cancer... Read More
22
Feb
2016
Promising respiratory drug focus of new clinical trial for Parkinson’s disease
GRAND RAPIDS, Mich. (February 22, 2016)—A medication approved to treat various respiratory diseases and that has demonstrated neuroprotective effects in preclinical studies... Read More
23
Sep
2014
Van Andel Research Institute joins The Cure Parkinson’s Trust to accelerate development of new Parkinson’s disease treatments
Grand Rapids, Mich. (Sept. 23, 2014) – Van Andel Research Institute (VARI) has partnered with UK-based research charity The Cure Parkinson’s Trust on... Read More